SelectScience InterviewsClinical Diagnostics
Inspiration to a Generation: A Spotlight on Dr. Brian Druker, Pioneer of Imatinib
11 Sept 2018
Having established the first drug to selectively target cancer cells, Imatinib, Dr. Brian Druker is heralded as a pioneer in the field of precision medicine. Here, Druker shares his personal motivation to study cancer, what it takes to reach a breakthrough, and how today’s technology is accelerating us towards the future of cancer therapy.
About the company

SelectScience
Established in July 1998, SelectScience is the fastest way to impartial, expert opinion about the best laboratory equipment and latest techniques.




















